Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Int J Mol Sci. 2024 Aug 24;25(17):9184. doi: 10.3390/ijms25179184.
Biological therapies have revolutionized medical treatment by targeting the key mediators or receptors involved in inflammatory responses, thereby effectively suppressing inflammation and achieving beneficial outcomes. They are more advanced than conventional therapies using corticosteroids and immunosuppressants, offering effective solutions for autoimmune diseases, cancer, transplant rejection, and various infectious diseases, including coronavirus disease 2019. Although they exert low immunosuppressive effects, biological therapies can reactivate specific biological targets associated with infections. This review summarizes the currently available biological therapies and discusses their immunosuppressive mechanisms and clinical applications, highlighting the variations in the types and frequencies of infection recurrence induced by different biological agents. Additionally, this review describes the risk factors associated with various biological agents, thus aiding clinicians in selecting the most appropriate biological therapy.
生物疗法通过靶向炎症反应中涉及的关键介质或受体,从而有效抑制炎症并取得有益的效果,从而彻底改变了医学治疗方法。与使用皮质类固醇和免疫抑制剂的传统疗法相比,它们更为先进,为自身免疫性疾病、癌症、移植排斥和各种传染病(包括 2019 年冠状病毒病)提供了有效的解决方案。尽管它们的免疫抑制作用较低,但生物疗法可以重新激活与感染相关的特定生物靶标。本综述总结了目前可用的生物疗法,并讨论了它们的免疫抑制机制和临床应用,强调了不同生物制剂引起的感染复发的类型和频率的变化。此外,本综述还描述了与各种生物制剂相关的风险因素,从而帮助临床医生选择最合适的生物疗法。